FLI1 and Ewing sarcoma: Therefore, in addition to Ewing sarcoma, targeted inhibition of OTUD7A may be relevant for other cancers dependent on FLI1 for proliferation, such as leukemia and kidney cancer (Figure S20G, Supporting Information).